Arden Trust’s Veracyte VCYT Stock Holding History

Arden Trust’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,753	Closed	-$91K	–	726
2020 Q1	$91K	Buy	+3,753	New	+$94.5K	0.02%	397

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Arden Trust's VCYT Position: Q2 2020 in Review

Arden Trust sold out of Veracyte (VCYT) in Q2 2020, closing a stake of 3,753 shares — an estimated $91K sold.

Arden Trust first reported a position in VCYT in Q1 2020 and held it in 1 quarter. The position peaked at $91K in Q1 2020. 166 funds tracked by Wall St. Rank hold VCYT as of Q2 2020.

Arden Trust reported no remaining Veracyte position as of Q2 2020 after selling out during the quarter.
Arden Trust sold 3,753 Veracyte shares in Q2 2020, an estimated $91K.
Arden Trust first reported a position in Veracyte in Q1 2020 and held it in 1 quarter.
Arden Trust's Veracyte position peaked at $91K in Q1 2020.
166 funds tracked by Wall St. Rank held Veracyte as of Q2 2020.

Based on Arden Trust's 13F filing for Q2 2020, filed 9 Jul 2020.